The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.
The global Alosetron market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alosetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alosetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alosetron include Sebela Pharmaceuticals, Amneal, Par Pharmaceutical and West-Ward Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alosetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alosetron.
Report Scope
The Alosetron market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alosetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alosetron manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sebela Pharmaceuticals
Amneal
Par Pharmaceutical
West-Ward Pharmaceuticals
Segment by Type
0.5 mg Tablets
1 mg Tablets
Segment by Application
Hospital
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alosetron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alosetron in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.
The global Alosetron market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alosetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alosetron is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Alosetron include Sebela Pharmaceuticals, Amneal, Par Pharmaceutical and West-Ward Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alosetron, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alosetron.
Report Scope
The Alosetron market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alosetron market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alosetron manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sebela Pharmaceuticals
Amneal
Par Pharmaceutical
West-Ward Pharmaceuticals
Segment by Type
0.5 mg Tablets
1 mg Tablets
Segment by Application
Hospital
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alosetron manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alosetron in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Alosetron Market Overview
1.1 Product Overview and Scope of Alosetron
1.2 Alosetron Segment by Type
1.2.1 Global Alosetron Market Value Comparison by Type (2024-2030)
1.2.2 0.5 mg Tablets
1.2.3 1 mg Tablets
1.3 Alosetron Segment by Application
1.3.1 Global Alosetron Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drugstore
1.4 Global Alosetron Market Size Estimates and Forecasts
1.4.1 Global Alosetron Revenue 2019-2030
1.4.2 Global Alosetron Sales 2019-2030
1.4.3 Global Alosetron Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alosetron Market Competition by Manufacturers
2.1 Global Alosetron Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alosetron Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alosetron Average Price by Manufacturers (2019-2024)
2.4 Global Alosetron Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alosetron, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alosetron, Product Type & Application
2.7 Alosetron Market Competitive Situation and Trends
2.7.1 Alosetron Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alosetron Players Market Share by Revenue
2.7.3 Global Alosetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alosetron Retrospective Market Scenario by Region
3.1 Global Alosetron Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alosetron Global Alosetron Sales by Region: 2019-2030
3.2.1 Global Alosetron Sales by Region: 2019-2024
3.2.2 Global Alosetron Sales by Region: 2025-2030
3.3 Global Alosetron Global Alosetron Revenue by Region: 2019-2030
3.3.1 Global Alosetron Revenue by Region: 2019-2024
3.3.2 Global Alosetron Revenue by Region: 2025-2030
3.4 North America Alosetron Market Facts & Figures by Country
3.4.1 North America Alosetron Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alosetron Sales by Country (2019-2030)
3.4.3 North America Alosetron Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alosetron Market Facts & Figures by Country
3.5.1 Europe Alosetron Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alosetron Sales by Country (2019-2030)
3.5.3 Europe Alosetron Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alosetron Market Facts & Figures by Country
3.6.1 Asia Pacific Alosetron Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alosetron Sales by Country (2019-2030)
3.6.3 Asia Pacific Alosetron Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Alosetron Market Facts & Figures by Country
3.7.1 Latin America Alosetron Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alosetron Sales by Country (2019-2030)
3.7.3 Latin America Alosetron Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alosetron Market Facts & Figures by Country
3.8.1 Middle East and Africa Alosetron Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alosetron Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alosetron Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alosetron Sales by Type (2019-2030)
4.1.1 Global Alosetron Sales by Type (2019-2024)
4.1.2 Global Alosetron Sales by Type (2025-2030)
4.1.3 Global Alosetron Sales Market Share by Type (2019-2030)
4.2 Global Alosetron Revenue by Type (2019-2030)
4.2.1 Global Alosetron Revenue by Type (2019-2024)
4.2.2 Global Alosetron Revenue by Type (2025-2030)
4.2.3 Global Alosetron Revenue Market Share by Type (2019-2030)
4.3 Global Alosetron Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alosetron Sales by Application (2019-2030)
5.1.1 Global Alosetron Sales by Application (2019-2024)
5.1.2 Global Alosetron Sales by Application (2025-2030)
5.1.3 Global Alosetron Sales Market Share by Application (2019-2030)
5.2 Global Alosetron Revenue by Application (2019-2030)
5.2.1 Global Alosetron Revenue by Application (2019-2024)
5.2.2 Global Alosetron Revenue by Application (2025-2030)
5.2.3 Global Alosetron Revenue Market Share by Application (2019-2030)
5.3 Global Alosetron Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sebela Pharmaceuticals
6.1.1 Sebela Pharmaceuticals Corporation Information
6.1.2 Sebela Pharmaceuticals Description and Business Overview
6.1.3 Sebela Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sebela Pharmaceuticals Alosetron Product Portfolio
6.1.5 Sebela Pharmaceuticals Recent Developments/Updates
6.2 Amneal
6.2.1 Amneal Corporation Information
6.2.2 Amneal Description and Business Overview
6.2.3 Amneal Alosetron Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amneal Alosetron Product Portfolio
6.2.5 Amneal Recent Developments/Updates
6.3 Par Pharmaceutical
6.3.1 Par Pharmaceutical Corporation Information
6.3.2 Par Pharmaceutical Description and Business Overview
6.3.3 Par Pharmaceutical Alosetron Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Par Pharmaceutical Alosetron Product Portfolio
6.3.5 Par Pharmaceutical Recent Developments/Updates
6.4 West-Ward Pharmaceuticals
6.4.1 West-Ward Pharmaceuticals Corporation Information
6.4.2 West-Ward Pharmaceuticals Description and Business Overview
6.4.3 West-Ward Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West-Ward Pharmaceuticals Alosetron Product Portfolio
6.4.5 West-Ward Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alosetron Industry Chain Analysis
7.2 Alosetron Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alosetron Production Mode & Process
7.4 Alosetron Sales and Marketing
7.4.1 Alosetron Sales Channels
7.4.2 Alosetron Distributors
7.5 Alosetron Customers
8 Alosetron Market Dynamics
8.1 Alosetron Industry Trends
8.2 Alosetron Market Drivers
8.3 Alosetron Market Challenges
8.4 Alosetron Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
